Cargando…

Why is the SARS-CoV-2 Omicron variant milder?

Detalles Bibliográficos
Autores principales:	Xia, Bingqing, Wang, Yi, Pan, Xiaoyan, Cheng, Xi, Ji, Hongying, Zuo, Xiaoli, Jiang, Hualiang, Li, Jia, Gao, Zhaobing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040510/ https://www.ncbi.nlm.nih.gov/pubmed/35497020 http://dx.doi.org/10.1016/j.xinn.2022.100251

Ejemplares similares

Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB
por: Wang, Yi, et al.
Publicado: (2023)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
por: Rahmani, Shayan, et al.
Publicado: (2022)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Why is SARS-CoV-2 infection milder among children?
por: Palmeira, Patricia, et al.
Publicado: (2020)

Omicron infection milder in nursing home residents
por: Katz, Morgan J, et al.
Publicado: (2022)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Role of Omicron variant of SARS-CoV-2 in children in Germany
por: Bittmann, Stefan
Publicado: (2022)

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant
por: Berkhout, Ben, et al.
Publicado: (2022)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Omicron variant of SARS-CoV-2 – A new kid on the block
por: Husain, Uneza, et al.
Publicado: (2022)

Pathogenicity of SARS‐CoV‐2 Omicron
por: Chu, Hin, et al.
Publicado: (2022)

Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases
por: Papagoras, Charalampos, et al.
Publicado: (2023)

Neuroinflammation in mild respiratory COVID-19: insights into cognitive impairment in milder cases
por: Li, Qian, et al.
Publicado: (2022)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Natural selection of the D614G mutation in SARS-CoV-2 Omicron (B.1.1.529) variant and its subvariants
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)

Preparation for the challenge of heavily mutated Omicron variant
por: Song, Yuanlin, et al.
Publicado: (2021)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Characteristics and prevention
por: He, Xuemei, et al.
Publicado: (2021)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
por: Li, Fu, et al.
Publicado: (2022)

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

SARS-CoV-2 infection and the brain: direct evidence for brain changes in milder cases
por: Sollmann, Nico, et al.
Publicado: (2022)

Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2
por: Xia, Bingqing, et al.
Publicado: (2023)

A PTG Variant Contributes to a Milder Phenotype in Lafora Disease
por: Guerrero, Rosa, et al.
Publicado: (2011)

Omicron: the highly mutational COVID-19 variant with immune escape
por: Khajotia, Rumi
Publicado: (2022)

Omicron variant: assessing the duration of viral shedding and its implications
por: Cevik, Muge, et al.
Publicado: (2023)

The Effect of Strict Lockdown on Omicron SARS-CoV-2 Variant Transmission in Shanghai
por: Yang, Haibo, et al.
Publicado: (2022)

Why we may need to rethink future SARS-CoV-2 vaccination strategies
por: Klimek, Peter
Publicado: (2021)

Possibility of COVID-19 eradication with evolution of a new omicron variant
por: Okpeku, Moses
Publicado: (2022)

Leaky splicing variant in sepiapterin reductase deficiency: Are milder cases escaping diagnosis?
por: Nakagama, Yu, et al.
Publicado: (2019)

Milder outcomes of SARS-CoV-2 genetically confirmed reinfections compared to primary infections with the delta variant: A retrospective case-control study
por: Suljič, Alen, et al.
Publicado: (2022)

Omicron variant in the current SARS-CoV-2 pandemic
por: Nasiri, Kaveh, et al.
Publicado: (2022)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Neutralization and Stability of SARS-CoV-2 Omicron Variant
por: Zeng, Cong, et al.
Publicado: (2021)

Recent insights into SARS‐CoV‐2 omicron variant
por: da Silva, Severino Jefferson Ribeiro, et al.
Publicado: (2022)

Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022)

Determinants of reinfection with SARS-CoV-2 Omicron variant
por: Bisharat, N., et al.
Publicado: (2023)

Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
por: Wei, Changshuo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qs8ao5151ghn6kj8s1p202jkp6